milrinone has been researched along with Arrhythmias, Cardiac in 28 studies
Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The altered pharmacokinetics of milrinone in renal impairment could result in an increased risk of cardiac arrhythmias." | 8.31 | Renal Dysfunction and Arrhythmia Association in Patients Receiving Milrinone After Cardiac Surgery. ( Henderson, JB; Kram, SJ; Levy, JH; Valkovec, AM, 2023) |
| "The purpose of this study was to determine whether a low-dose β-blocker, in combination with milrinone, improves cardiac function in acute decompensated heart failure (ADHF) with tachycardia." | 7.78 | Low-dose β-blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure. ( Doi, M; Fukuta, S; Kobayashi, S; Matsuzaki, M; Murakami, W; Nao, T; Okamura, T; Okuda, S; Susa, T; Tanaka, T; Wada, Y; Yamada, J; Yano, M, 2012) |
| " The aim of this study was to compare the effects of several inotropic drugs on survival and the occurrence of arrhythmias in the treatment of amitriptyline poisoning." | 7.69 | Effects of epinephrine, norepinephrine, magnesium sulfate, and milrinone on survival and the occurrence of arrhythmias in amitriptyline poisoning in the rat. ( Abrahamsson, J; Knudsen, K, 1994) |
| " Flosequinan, milrinone, isoprenaline and forskolin given intravenously at similarly hypotensive doses have been evaluated in separate studies for their effect on ischaemia-induced arrhythmias and on ventricular cyclic nucleotide content following coronary artery ligation in the pentobarbitone anaesthetized rat." | 7.68 | Effect of flosequinan on ischaemia-induced arrhythmias and on ventricular cyclic nucleotide content in the anaesthetized rat. ( Dickinson, K; Foster, GA; Frodsham, G; Jones, RB, 1993) |
| "The effects of milrinone and pimobendan upon the initiation of programmed ventricular stimulation-induced ventricular tachycardia (VT) and the incidence of lethal ischemic ventricular arrhythmias were assessed in conscious dogs with recent anterior myocardial infarctions." | 7.67 | Effects of the positive inotropic agents milrinone and pimobendan on the development of lethal ischemic arrhythmias in conscious dogs with recent myocardial infarction. ( Driscoll, EM; Frye, JW; Kitzen, JM; Lucchesi, BR; Lynch, JJ; Uprichard, AC, 1989) |
| "To determine whether oral milrinone therapy has an effect on complex ventricular arrhythmias in patients with severe congestive heart failure and, if so, whether a change in the severity of complex ventricular arrhythmias after 1 week of milrinone therapy is associated with a change in the mode or frequency of cardiac mortality, a retrospective analysis was performed to determine the frequency of ventricular tachycardia and the density of ventricular couplets on 24-hour ambulatory electrocardiographic recordings performed before and 1 week after initiation of oral milrinone therapy in 74 consecutive patients with New York Heart Association functional class III or IV congestive heart failure." | 7.67 | Effects of milrinone on complex ventricular arrhythmias in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. ( Antman, EM; Baim, DS; Colucci, WS; Friedman, PL; Gauthier, DF; Ludmer, PL; Rocco, MB, 1987) |
| "Milrinone is a potent non-catecholamine, non-glycoside inotropic agent that can improve hemodynamic performance and functional capacity in patients with severe congestive heart failure." | 7.67 | Milrinone in congestive heart failure: observations on ambulatory ventricular arrhythmias. ( Cody, RJ; Holmes, JR; Kligfield, P; Kubo, SH, 1985) |
| "Milrinone-associated cardiomyopathy and arrhythmia can occur in patients with cerebral vasospasm." | 5.48 | Milrinone-Associated Cardiomyopathy and Arrhythmia in Cerebral Vasospasm. ( Aoun, SG; Davies, MT; El Ahmadieh, TY; Kafka, B; White, JA; Wu, EM, 2018) |
| "The overall arrhythmia incidence was 50%, most commonly monomorphic ventricular tachycardia (n = 85, 12%), junctional ectopic tachycardia (n = 69, 10%), accelerated junctional rhythm (n = 58, 8%), and atrial tachyarrhythmias (including atrial fibrillation, atrial flutter, and ectopic or chaotic atrial tachycardia, n = 58, 8%)." | 5.37 | Relation of milrinone after surgery for congenital heart disease to significant postoperative tachyarrhythmias. ( Borgman, KY; Fish, FA; Kannankeril, PJ; Owen, J; Smith, AH, 2011) |
| "Levosimendan has a more beneficial profile than milrinone regarding the development of ventricular arrhythmias during and after regional myocardial ischemia." | 5.33 | Effect of levosimendan and milrinone on regional myocardial ischemia/reperfusion-induced arrhythmias in dogs. ( Papp, JG; Pollesello, P; Varró, AF; Végh, AS, 2006) |
| "We monitored ventricular arrhythmias during a 24-hour baseline and 48-hour milrinone infusion period in 12 patients with chronic heart failure." | 5.27 | Occurrence of ventricular arrhythmias in patients receiving acute and chronic infusions of milrinone. ( Anderson, JL; Askins, JC; Gilbert, EM; Lutz, JR; Menlove, RL, 1986) |
| "Controlled and uncontrolled hemodynamic and clinical studies have noted that the long-term treatment of patients with chronic heart failure with phosphodiesterase (PDE) inhibitors, such as amrinone, milrinone, enoximone and imazodan, may accelerate progression of the underlying disease and provoke serious ventricular arrhythmias." | 5.06 | Effect of phosphodiesterase inhibitors on survival of patients with chronic congestive heart failure. ( Packer, M, 1989) |
| "The altered pharmacokinetics of milrinone in renal impairment could result in an increased risk of cardiac arrhythmias." | 4.31 | Renal Dysfunction and Arrhythmia Association in Patients Receiving Milrinone After Cardiac Surgery. ( Henderson, JB; Kram, SJ; Levy, JH; Valkovec, AM, 2023) |
| "The purpose of this study was to determine whether a low-dose β-blocker, in combination with milrinone, improves cardiac function in acute decompensated heart failure (ADHF) with tachycardia." | 3.78 | Low-dose β-blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure. ( Doi, M; Fukuta, S; Kobayashi, S; Matsuzaki, M; Murakami, W; Nao, T; Okamura, T; Okuda, S; Susa, T; Tanaka, T; Wada, Y; Yamada, J; Yano, M, 2012) |
| " The aim of this study was to compare the effects of several inotropic drugs on survival and the occurrence of arrhythmias in the treatment of amitriptyline poisoning." | 3.69 | Effects of epinephrine, norepinephrine, magnesium sulfate, and milrinone on survival and the occurrence of arrhythmias in amitriptyline poisoning in the rat. ( Abrahamsson, J; Knudsen, K, 1994) |
| " Flosequinan, milrinone, isoprenaline and forskolin given intravenously at similarly hypotensive doses have been evaluated in separate studies for their effect on ischaemia-induced arrhythmias and on ventricular cyclic nucleotide content following coronary artery ligation in the pentobarbitone anaesthetized rat." | 3.68 | Effect of flosequinan on ischaemia-induced arrhythmias and on ventricular cyclic nucleotide content in the anaesthetized rat. ( Dickinson, K; Foster, GA; Frodsham, G; Jones, RB, 1993) |
| "The effects of milrinone and pimobendan upon the initiation of programmed ventricular stimulation-induced ventricular tachycardia (VT) and the incidence of lethal ischemic ventricular arrhythmias were assessed in conscious dogs with recent anterior myocardial infarctions." | 3.67 | Effects of the positive inotropic agents milrinone and pimobendan on the development of lethal ischemic arrhythmias in conscious dogs with recent myocardial infarction. ( Driscoll, EM; Frye, JW; Kitzen, JM; Lucchesi, BR; Lynch, JJ; Uprichard, AC, 1989) |
| "To determine whether oral milrinone therapy has an effect on complex ventricular arrhythmias in patients with severe congestive heart failure and, if so, whether a change in the severity of complex ventricular arrhythmias after 1 week of milrinone therapy is associated with a change in the mode or frequency of cardiac mortality, a retrospective analysis was performed to determine the frequency of ventricular tachycardia and the density of ventricular couplets on 24-hour ambulatory electrocardiographic recordings performed before and 1 week after initiation of oral milrinone therapy in 74 consecutive patients with New York Heart Association functional class III or IV congestive heart failure." | 3.67 | Effects of milrinone on complex ventricular arrhythmias in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. ( Antman, EM; Baim, DS; Colucci, WS; Friedman, PL; Gauthier, DF; Ludmer, PL; Rocco, MB, 1987) |
| "Milrinone is a potent non-catecholamine, non-glycoside inotropic agent that can improve hemodynamic performance and functional capacity in patients with severe congestive heart failure." | 3.67 | Milrinone in congestive heart failure: observations on ambulatory ventricular arrhythmias. ( Cody, RJ; Holmes, JR; Kligfield, P; Kubo, SH, 1985) |
| " Patients were allocated to each dosage group sequentially, not randomly." | 2.67 | Intravenous milrinone following cardiac surgery: I. Effects of bolus infusion followed by variable dose maintenance infusion. The European Milrinone Multicentre Trial Group. ( Feneck, RO, 1992) |
| "Milrinone-associated cardiomyopathy and arrhythmia can occur in patients with cerebral vasospasm." | 1.48 | Milrinone-Associated Cardiomyopathy and Arrhythmia in Cerebral Vasospasm. ( Aoun, SG; Davies, MT; El Ahmadieh, TY; Kafka, B; White, JA; Wu, EM, 2018) |
| "The overall arrhythmia incidence was 50%, most commonly monomorphic ventricular tachycardia (n = 85, 12%), junctional ectopic tachycardia (n = 69, 10%), accelerated junctional rhythm (n = 58, 8%), and atrial tachyarrhythmias (including atrial fibrillation, atrial flutter, and ectopic or chaotic atrial tachycardia, n = 58, 8%)." | 1.37 | Relation of milrinone after surgery for congenital heart disease to significant postoperative tachyarrhythmias. ( Borgman, KY; Fish, FA; Kannankeril, PJ; Owen, J; Smith, AH, 2011) |
| " Beta-blocker dosages were titrated, and three patients achieved the target beta-blocker dosage established for stage A-C heart failure." | 1.34 | Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone. ( Earl, GL; Fitzpatrick, JM; Narula, J; Verbos-Kazanas, MA, 2007) |
| "Levosimendan has a more beneficial profile than milrinone regarding the development of ventricular arrhythmias during and after regional myocardial ischemia." | 1.33 | Effect of levosimendan and milrinone on regional myocardial ischemia/reperfusion-induced arrhythmias in dogs. ( Papp, JG; Pollesello, P; Varró, AF; Végh, AS, 2006) |
| "Significant proarrhythmia is uncommon, but can occur." | 1.28 | Electrophysiology of phosphodiesterase inhibitors. ( Goldstein, RA; Naccarelli, GV, 1989) |
| "Milrinone is a newly developed analogue of amrinone possessing potent positive inotropic action." | 1.27 | The effects of milrinone on conduction, reflection, and automaticity in canine Purkinje fibers. ( Antzelevitch, C; Davidenko, JM, 1984) |
| "We monitored ventricular arrhythmias during a 24-hour baseline and 48-hour milrinone infusion period in 12 patients with chronic heart failure." | 1.27 | Occurrence of ventricular arrhythmias in patients receiving acute and chronic infusions of milrinone. ( Anderson, JL; Askins, JC; Gilbert, EM; Lutz, JR; Menlove, RL, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (32.14) | 18.7374 |
| 1990's | 7 (25.00) | 18.2507 |
| 2000's | 5 (17.86) | 29.6817 |
| 2010's | 5 (17.86) | 24.3611 |
| 2020's | 2 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Jung, RG | 1 |
| Di Santo, P | 1 |
| Mathew, R | 1 |
| Simard, T | 1 |
| Parlow, S | 1 |
| Weng, W | 1 |
| Abdel-Razek, O | 1 |
| Malhotra, N | 1 |
| Cheung, M | 1 |
| Hutson, JH | 1 |
| Marbach, JA | 1 |
| Motazedian, P | 1 |
| Thibert, MJ | 1 |
| Fernando, SM | 1 |
| Nery, PB | 1 |
| Nair, GM | 1 |
| Russo, JJ | 1 |
| Hibbert, B | 1 |
| Ramirez, FD | 1 |
| Valkovec, AM | 1 |
| Kram, SJ | 1 |
| Henderson, JB | 1 |
| Levy, JH | 1 |
| Wu, EM | 1 |
| El Ahmadieh, TY | 1 |
| Kafka, B | 1 |
| Davies, MT | 1 |
| Aoun, SG | 1 |
| White, JA | 1 |
| Ushio, M | 1 |
| Egi, M | 1 |
| Wakabayashi, J | 1 |
| Nishimura, T | 1 |
| Miyatake, Y | 1 |
| Obata, N | 1 |
| Mizobuchi, S | 1 |
| Smith, AH | 1 |
| Owen, J | 1 |
| Borgman, KY | 1 |
| Fish, FA | 1 |
| Kannankeril, PJ | 1 |
| Kobayashi, S | 1 |
| Susa, T | 1 |
| Tanaka, T | 1 |
| Murakami, W | 1 |
| Fukuta, S | 1 |
| Okuda, S | 1 |
| Doi, M | 1 |
| Wada, Y | 1 |
| Nao, T | 1 |
| Yamada, J | 1 |
| Okamura, T | 1 |
| Yano, M | 1 |
| Matsuzaki, M | 1 |
| Yasumura, Y | 1 |
| Cremers, B | 1 |
| Scheler, M | 1 |
| Maack, C | 1 |
| Wendler, O | 1 |
| Schäfers, HJ | 1 |
| Südkamp, M | 1 |
| Böhm, M | 1 |
| Bekhit, AA | 1 |
| Baraka, AM | 1 |
| Papp, JG | 1 |
| Pollesello, P | 1 |
| Varró, AF | 1 |
| Végh, AS | 1 |
| Earl, GL | 1 |
| Verbos-Kazanas, MA | 1 |
| Fitzpatrick, JM | 1 |
| Narula, J | 1 |
| Davidenko, JM | 1 |
| Antzelevitch, C | 1 |
| Konstam, MA | 1 |
| Cody, RJ | 2 |
| Knudsen, K | 1 |
| Abrahamsson, J | 1 |
| Jones, RB | 1 |
| Frodsham, G | 1 |
| Dickinson, K | 1 |
| Foster, GA | 1 |
| Shubert, J | 1 |
| Mancano, MA | 1 |
| Pina, IL | 1 |
| Milfred, SK | 1 |
| Carceles, MD | 1 |
| Aleixandre, F | 1 |
| Fuente, T | 1 |
| López-Vidal, J | 1 |
| Laorden, ML | 1 |
| Feneck, RO | 1 |
| Trolese-Mongheal, Y | 1 |
| Barthelemy, J | 1 |
| Paire, M | 1 |
| Duchene-Marullaz, P | 1 |
| Ferrick, KJ | 1 |
| Fein, SA | 1 |
| Ferrick, AM | 1 |
| Doyle, JT | 1 |
| Holbrook, M | 1 |
| Coker, SJ | 1 |
| Lynch, JJ | 1 |
| Uprichard, AC | 1 |
| Frye, JW | 1 |
| Driscoll, EM | 1 |
| Kitzen, JM | 1 |
| Lucchesi, BR | 1 |
| Packer, M | 1 |
| Naccarelli, GV | 1 |
| Goldstein, RA | 1 |
| Tommaso, CL | 1 |
| Ludmer, PL | 1 |
| Baim, DS | 1 |
| Antman, EM | 1 |
| Gauthier, DF | 1 |
| Rocco, MB | 1 |
| Friedman, PL | 1 |
| Colucci, WS | 1 |
| Anderson, JL | 1 |
| Askins, JC | 1 |
| Gilbert, EM | 1 |
| Menlove, RL | 1 |
| Lutz, JR | 1 |
| Holmes, JR | 1 |
| Kubo, SH | 1 |
| Kligfield, P | 1 |
2 reviews available for milrinone and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Impact of Milrinone Administration in Adult Cardiac Surgery Patients: Updated Meta-Analysis.
Topics: Arrhythmias, Cardiac; Cardiac Surgical Procedures; Cardiotonic Agents; Drug Administration Schedule; | 2016 |
Non-glycoside, non-catecholamine inotropic agents in the treatment of congestive heart failure.
Topics: Administration, Oral; Aminopyridines; Amrinone; Arrhythmias, Cardiac; Calcium; Cardiac Output; Cardi | 1986 |
3 trials available for milrinone and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Arrhythmic Events and Mortality in Patients With Cardiogenic Shock on Inotropic Support: Results of the DOREMI Randomized Trial.
Topics: Arrhythmias, Cardiac; Dobutamine; Humans; Milrinone; Shock, Cardiogenic; Stroke Volume; Ventricular | 2023 |
Intravenous milrinone following cardiac surgery: I. Effects of bolus infusion followed by variable dose maintenance infusion. The European Milrinone Multicentre Trial Group.
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Cardiac Output | 1992 |
Effect of phosphodiesterase inhibitors on survival of patients with chronic congestive heart failure.
Topics: Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Clinical Trials as Topic; Heart Failure; Humans; | 1989 |
23 other studies available for milrinone and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Renal Dysfunction and Arrhythmia Association in Patients Receiving Milrinone After Cardiac Surgery.
Topics: Adult; Arrhythmias, Cardiac; Cardiotonic Agents; Coronary Artery Bypass; Humans; Kidney Diseases; Mi | 2023 |
Milrinone-Associated Cardiomyopathy and Arrhythmia in Cerebral Vasospasm.
Topics: Adult; Arrhythmias, Cardiac; Cardiomyopathies; Female; Humans; Infusions, Intravenous; Milrinone; Re | 2018 |
Relation of milrinone after surgery for congenital heart disease to significant postoperative tachyarrhythmias.
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Child; Child, Preschool; Dose- | 2011 |
Low-dose β-blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure.
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Cardiotonic Agents; C | 2012 |
Combination of β-blocker and milrinone for acute heart failure.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Cardiotonic Agents; Female; Heart Failure; Hemody | 2012 |
Effects of sildenafil (viagra) on human myocardial contractility, in vitro arrhythmias, and tension of internal mammaria arteries and saphenous veins.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Arrhythmias, Cardiac; Cyclic Nucleotide Phosphodiesterases, Typ | 2003 |
Novel milrinone analogs of pyridine-3-carbonitrile derivatives as promising cardiotonic agents.
Topics: Adenosine Deaminase; Administration, Oral; Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Diseas | 2005 |
Effect of levosimendan and milrinone on regional myocardial ischemia/reperfusion-induced arrhythmias in dogs.
Topics: Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Coronary Vessels; Dogs; Electrophysiology; Female | 2006 |
Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.
Topics: Adrenergic beta-Antagonists; Aged; Arrhythmias, Cardiac; Blood Pressure; Carbazoles; Cardiac Output, | 2007 |
The effects of milrinone on conduction, reflection, and automaticity in canine Purkinje fibers.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Dogs; Heart Conduction System; | 1984 |
Short-term use of intravenous milrinone for heart failure.
Topics: Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Cardiac Output, Low; Cardiotonic Agents; Diast | 1995 |
Effects of epinephrine, norepinephrine, magnesium sulfate, and milrinone on survival and the occurrence of arrhythmias in amitriptyline poisoning in the rat.
Topics: Amitriptyline; Analysis of Variance; Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Chi-Square D | 1994 |
Effect of flosequinan on ischaemia-induced arrhythmias and on ventricular cyclic nucleotide content in the anaesthetized rat.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Anesthesia; Animals; Arrhythmias, Cardiac; Blood Pressu | 1993 |
Criteria for use of intravenous milrinone in adult inpatients.
Topics: Adult; Arrhythmias, Cardiac; Cardiotonic Agents; Female; Heart Failure; Humans; Hypotension; Infusio | 1995 |
Combined phosphodiesterase inhibition and beta-blockade in the GI104313, decreases ischemia-induced arrhythmias in the rat.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Hemodynamics; Ma | 2001 |
Arrhythmogenic potencies of amrinone and milrinone in unanesthetized dogs with myocardial infarct.
Topics: Amrinone; Analysis of Variance; Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Dogs; Heart Rate; | 1992 |
Effect of milrinone on ventricular arrhythmias in congestive heart failure.
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiotonic Agents; Female; Heart Failure; Hum | 1990 |
Comparison of the effects of isobutylmethylxanthine and milrinone on ischaemia-induced arrhythmias and platelet aggregation in anaesthetized rabbits.
Topics: 1-Methyl-3-isobutylxanthine; Anesthesia; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bloo | 1989 |
Effects of the positive inotropic agents milrinone and pimobendan on the development of lethal ischemic arrhythmias in conscious dogs with recent myocardial infarction.
Topics: Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Coronary Vessels; Dogs; Electric Stimulation; Ele | 1989 |
Electrophysiology of phosphodiesterase inhibitors.
Topics: Amrinone; Arrhythmias, Cardiac; Cardiotonic Agents; Electrocardiography; Electrophysiology; Heart Co | 1989 |
Effects of milrinone on complex ventricular arrhythmias in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Topics: Adult; Aged; Ambulatory Care; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Coronary Disease; Elect | 1987 |
Occurrence of ventricular arrhythmias in patients receiving acute and chronic infusions of milrinone.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiotonic Agents; Drug Administration Schedule; Female; Heart F | 1986 |
Milrinone in congestive heart failure: observations on ambulatory ventricular arrhythmias.
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Arrhythmias, Cardiac; Cardiotonic Agents; Electr | 1985 |